{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:50:51Z","timestamp":1787914251907,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["310046"],"award-info":[{"award-number":["310046"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Global Health"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12992-017-0285-x","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T08:22:51Z","timestamp":1503390171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016"],"prefix":"10.1186","volume":"13","author":[{"given":"Marc-Andr\u00e9","family":"Gagnon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karena D.","family":"Volesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"285_CR1","unstructured":"Turk S. Generic Pharmaceutical Manufacturing in the US. IBIS World Industry Report, 2015 32541b. Accessed 15 Dec 2016."},{"key":"285_CR2","unstructured":"Bollyky TJ, Kesselheim AS. Can Drug Reimportation Address High Generic Drug Prices? Hutchins Center Working Paper #29. Center for Health Policy at Brookings: May 2017. \nhttps:\/\/www.brookings.edu\/wp-content\/uploads\/2017\/05\/wp29_bollykykesselheim_drugimportation.pdf\n\n. Accessed 8 Aug 2017."},{"issue":"6","key":"285_CR3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1470-2045(15)70265-2","volume":"16","author":"L Editorial","year":"2015","unstructured":"Editorial L. Generic drug market: growing and merging. Lancet Oncol. 2015;16(6):595.","journal-title":"Lancet Oncol"},{"key":"285_CR4","unstructured":"Wieczner J. The real reasons for the pharma merger boom. Fortune. 2015; \nhttp:\/\/fortune.com\/2015\/07\/28\/why-pharma-mergers-are-booming\/\n\n. Accessed 5 Jan 2017"},{"key":"285_CR5","unstructured":"Philips M. Monster deals, big questions. Bloomberg Business 2015. \nhttp:\/\/www.bloomberg.com\/news\/articles\/2015-12-23\/m-a-wave-can-signal-economic-downturn-maybe-not-this-time\n\n. Accessed 24 Feb 2016."},{"key":"285_CR6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/mde.1343","volume":"28","author":"P Danzon","year":"2007","unstructured":"Danzon P, Epstein A, Nicholson S. Mergers and acquisitions in the pharmaceutical and biotech industries. Manage Decis Econ. 2007;28:307\u201328.","journal-title":"Manage Decis Econ"},{"key":"285_CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijindorg.2008.04.003","volume":"27","author":"C Ornaghi","year":"2009","unstructured":"Ornaghi C. Mergers and innovation in big pharma. Int J Indust Org. 2009;27:70\u20139.","journal-title":"Int J Indust Org"},{"issue":"1","key":"285_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/B:SCIE.0000013304.40957.0d","volume":"59","author":"ME Koenig","year":"2004","unstructured":"Koenig ME, Mezick EM. Impact of mergers and acquisitions on research productivity within the pharmaceutical industry. Scientometrics. 2004;59(1):157\u201369.","journal-title":"Scientometrics"},{"issue":"1","key":"285_CR9","first-page":"58","volume":"1","author":"M Hassan","year":"2007","unstructured":"Hassan M, Patro DK, Tuckman H, Wang X. Do mergers and acquisitions create shareholder wealth in the pharmaceutical industry? Int J Healthc Mark. 2007;1(1):58\u201378.","journal-title":"Int J Healthc Mark"},{"issue":"5","key":"285_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40290-014-0066-2","volume":"28","author":"P Kavanos","year":"2014","unstructured":"Kavanos P, Angelis A. Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1? Pharm Med. 2014;28(5):245\u20138.","journal-title":"Pharm Med"},{"issue":"20","key":"285_CR11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMp1408376","volume":"371","author":"JD Alpern","year":"2014","unstructured":"Alpern JD, Stauffer WM, Kesselheim AS. High-cost generic drugs; implications for patients and policymakers. N Engl J Med. 2014;371(20):1859\u201362.","journal-title":"N Engl J Med"},{"issue":"5","key":"285_CR12","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.2105\/AJPH.2013.301239","volume":"103","author":"SO Schweitzer","year":"2003","unstructured":"Schweitzer SO. How the Food and Drug Administration can solve the prescription drug shortage problem. Am J Public Health. 2003;103(5):e10\u20134.","journal-title":"Am J Public Health"},{"key":"285_CR13","unstructured":"Department of Health and Human Resources. Understanding Recent Trends in Generic Drug Prices. ASPE Issue Brief, January 27 2016. \nhttps:\/\/aspe.hhs.gov\/pdf-report\/understanding-recent-trends-generic-drug-prices\n\n. Accessed 15 Feb 2017."},{"issue":"9","key":"285_CR14","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1377\/hlthaff.2015.1636","volume":"35","author":"A Aitken","year":"2016","unstructured":"Aitken A, Berndt ER, Cutler D, Kleinrock M, Maini L. Has the era of slow growth for prescription drug spending ended? Health Aff. 2016;35(9):1593\u2013603.","journal-title":"Health Aff"},{"issue":"4","key":"285_CR15","first-page":"10","volume":"7","author":"MA Gagnon","year":"2012","unstructured":"Gagnon MA. Drug shortages: searching for a cure. Healthc Policy. 2012;7(4):10\u20137.","journal-title":"Healthc Policy"},{"key":"285_CR16","unstructured":"The Multi-Stakeholder Steering Committee on Drug Shortages in Canada. Preventing Drug Shortages: Identifying Risks and Strategies to Address Manufacturing-Related Drug Shortages in Canada: 2017. Accessed 14 Jul 2017: \nhttps:\/\/www.drugshortagescanada.ca\/files\/MSSC_Causes_and_Prevention_2017.pdf"},{"key":"285_CR17","doi-asserted-by":"crossref","unstructured":"Dave CV, Kesselheim AS, Fox E, Qiu P, Hartzema A. High Generic Drug Prices and Market Competition; A Retrospective Cohort. Annals of Internal Medicine. 2017;167(3):145-51.","DOI":"10.7326\/M16-1432"},{"key":"285_CR18","unstructured":"Harding D. Gaining Market Share in the Generic Drug Industry through Acquisitions and Partnerships. Thomson Reuters White Paper, 2010. \nhttp:\/\/thomsonreuters.com\/content\/dam\/openweb\/documents\/pdf\/pharma-life-sciences\/white-paper\/newport-deals.pdf\n\n. Accessed 10 Feb 2017."},{"key":"285_CR19","unstructured":"Torreya Partners. Generic Pharmaceutical Industry Yearbook. Presentation for GPhA Conference, February 2016. \nhttp:\/\/www.torreyapartners.com\/documents\/generic-pharmaceutical-industry-yearbook-torreya-feb2016-gpha.pdf\n\n. Accessed 10 Feb 2017."},{"issue":"5","key":"285_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jama.2015.18720","volume":"315","author":"JA Greene","year":"2016","unstructured":"Greene JA, Anderson G, Sharstein JM. Role of the FDA in affordability of off-patent pharmaceuticals. JAMA. 2016;315(5):461\u20132.","journal-title":"JAMA"},{"key":"285_CR21","unstructured":"Chen Y, Varghese R, Prescott J. Generic Market Overview: Standing at the Top of the Patent Cliff. Pharmacy Times, August 30 2012. \nhttp:\/\/www.pharmacytimes.com\/publications\/supplement\/2012\/generic-supplement-2012\/generic-market-overview-standing-at-the-top-of-the-patent-cliff\n\n. Accessed 10 Feb 2017."},{"key":"285_CR22","unstructured":"Hirschler B. Drug shortages prompt question: are some medicines too cheap? Health news, April 1 2016. \nhttp:\/\/www.reuters.com\/article\/us-health-medicine-shortages-insight-idUSKCN0WY3NT\n\n. Accessed 10 Feb 2017."},{"key":"285_CR23","unstructured":"United States Government Accountability Office. Generic Drugs Under Medicare; Part D Generic Drug Prices Declined Overall, but Some Had Extraordinary Price Increases. Washington D.C.: GAO 16\u2013706; 2016."},{"key":"285_CR24","unstructured":"Milne V, Tepper J, Buchanan F. Drug Shortages \u2018the New Normal\u2019 and Hard to Fix. Healthy Debates: 13 July 2017. \nhttp:\/\/healthydebate.ca\/2017\/07\/topic\/drug-shortages-new-normal-hard-fix\n\n. Accessed 8 Aug 2017."},{"key":"285_CR25","unstructured":"Gagnon MA. Informations compl\u00e9mentaires quant au projet de loi 81 (Loi visant \u00e0 r\u00e9duire le co\u00fbt de certains m\u00e9dicaments couverts par le r\u00e9gime g\u00e9n\u00e9ral d\u2019assurance m\u00e9dicaments en permettant le recours \u00e0 une proc\u00e9dure d\u2019appel d\u2019offres). Memoir submitted to Commission de la sant\u00e9 et des services sociaux, Quebec National Assembly, March 2016. \nhttp:\/\/www.assnat.qc.ca\/Media\/Process.aspx?MediaId=ANQ.Vigie.Bll.DocumentGenerique_111977&process=Default&token=ZyMoxNwUn8ikQ+TRKYwPCjWrKwg+vIv9rjij7p3xLGTZDmLVSmJLoqe\/vG7\/YWzz\n\n. Accessed 10 Feb 2017."},{"issue":"13","key":"285_CR26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1503\/cmaj.121367","volume":"185","author":"M Law","year":"2013","unstructured":"Law M, Kratzer J. The road to competitive drug prices in Canada. CMAJ. 2013;185(13):1141\u20134.","journal-title":"CMAJ"}],"container-title":["Globalization and Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-017-0285-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T08:23:20Z","timestamp":1503390200000},"score":1,"resource":{"primary":{"URL":"http:\/\/globalizationandhealth.biomedcentral.com\/articles\/10.1186\/s12992-017-0285-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1186\/s12992-017-0285-x","relation":{},"ISSN":["1744-8603"],"issn-type":[{"value":"1744-8603","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]},"article-number":"62"}}